Plant viruses pose a serious and ongoing threat to global agriculture in tropical to temperate regions. Among the most damaging are begomoviruses, a group of DNA viruses spread by whiteflies that ...
ElevateBio Life Edit (R) is the Company's gene editing technologies and R&D business, focused on building the world's largest gene editing toolbox to expand addressable diseases and open a new ...
SpliceBio, a clinical-stage genetic medicines company pioneering protein splicing to address diseases caused by mutations in large genes, today announced that the first patient has been dosed in the ...
Cell and gene therapies use the body's building blocks - cells and genetic material - to boost the immune system or correct ...
Multi-asset pipeline with significant targeted data readouts and milestones -- Two lead ophthalmic gene therapy programs in clinical trials ...
Gene therapy ‘switch’ may offer non-addictive pain relief. New approach targets pain signals while leaving the rest of the brain untouched.
Bionova Scientific LLC, an Asahi Kasei company and a bespoke contract development and manufacturing organization (CDMO), announced a strategic manufacturing alliance with Syenex, a genetic medicines ...
The gene therapy market is surging toward $36.55 billion by 2032, powered by rising demand for curative treatments that target genetic diseases at their source([1]) . The FDA approved three ...
A retired HGV driver was the first person in the world to take part in a clinical trial to extend the lifespan of blood ...
John MacDonald, 73, took part in a clinical trial using gene therapy to extend the lifespan of blood vessels in the heart ...
Ultragenyx Pharmaceutical (RARE) stock is in focus as the company completes FDA rolling submission for FDA approval of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback